In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Motorola Inc.

www.motorola.com

Latest From Motorola Inc.

Appointments: Lilly, Kiadis, Pliant, Alma, NeuroVia and Nektar Therapeutics

This week's roundup includes a handful of promotions by Eli Lilly, and various board and high-level appointments by companies including Kiadis Pharma, Aeterna Zentaris, Dermavant Sciences and Pliant Therapeutics.

Appointments BioPharmaceutical

Wireless Technology And The Rise Of “Anywhere” Monitoring

The emerging market for wireless and remote monitoring technologies comes at a time when providers are looking for new tools to not only keep patients out of the hospital, but also to prevent unnecessary readmissions. These goals, along with a growing list of enabling technologies in the pipeline, are helping drive health care toward an era of unprecedented connectivity – one in which physicians and other care givers are able to monitor and even treat patients whenever needed wherever they may be – a shift that many believe will profoundly change health care as we know it.

Medical Device Consumer

Can Nanotech Be a Game-Changer for In Vitro Diagnostics?

People have awakened to the opportunities in diagnostics. Molecular information offers the potential for increased test sensitivity, and reduced upfront sample prep using nanotechnology could provide the means for many gene- and protein-based diagnostic tests to transition out of the central lab. Nanotech may also enable the use of newly discovered or newly usable biomarkers. Finally, unlike the traditional point-of-care model, a new wave of nanotech-based instruments could bring testing even closer to the patient.
Medical Device

LifeSync Corp.

LifeSync is discovering that the introduction of its wireless electrocardiogram (ECG) data communication system, which eliminates the lead wires of traditional ECG systems, while not necessarily enabling remote communications, is bringing clinical and economic advantages to hospitals.
Medical Device
See All

Company Information

  • Industry
  • Diversified
  • Research, Analytical Equipment & Supplies
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Motorola Inc.
  • Senior Management
  • Christopher B Galvin, Chmn. & CEO
    Carl F Koenemann, CFO
    William V Braun, VP, R&D
    Robert L Growney, Pres. & COO
  • Contact Info
  • Motorola Inc.
    Phone: (847) 576-5000
    1303 East Algonquin Rd.
    Schaumburg, IL 60196
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register